| scholarly article | Q13442814 |
| P50 | author | Naftali Kaminski | Q41048454 |
| Jen-hwa Chu | Q42886051 | ||
| P2093 | author name string | Koji Sakamoto | |
| Qin Li | |||
| Argyris Tzouvelekis | |||
| Erica L Herzog | |||
| Jose D Herazo-Maya | |||
| Hongyi Pan | |||
| Danielle Antin-Ozerkis | |||
| Changwan Ryu | |||
| Mridu Gulati | |||
| Martin Slade | |||
| Gabriel Ibarra | |||
| Giuseppe Deiuliis | |||
| P2860 | cites work | Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis | Q24817140 |
| Molecular biomarkers in idiopathic pulmonary fibrosis | Q27025340 | ||
| Role of matrix metalloproteinases in the pathogenesis of idiopathic pulmonary fibrosis | Q28069417 | ||
| Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial | Q28250518 | ||
| Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis | Q28291143 | ||
| MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis | Q28472658 | ||
| Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis | Q28943334 | ||
| Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study | Q28943525 | ||
| Palliative care and location of death in decedents with idiopathic pulmonary fibrosis | Q30366412 | ||
| Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model | Q33955628 | ||
| The clinical course of patients with idiopathic pulmonary fibrosis | Q33987940 | ||
| Incidence and prevalence of idiopathic pulmonary fibrosis | Q33997249 | ||
| Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans | Q34028910 | ||
| Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis | Q34629559 | ||
| Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. | Q34786695 | ||
| Extensive phenotyping of individuals at risk for familial interstitial pneumonia reveals clues to the pathogenesis of interstitial lung disease. | Q35153490 | ||
| Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis | Q35683018 | ||
| Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers. | Q35766847 | ||
| Allele-specific transactivation of matrix metalloproteinase 7 by FOXA2 and correlation with plasma levels in idiopathic pulmonary fibrosis | Q35902335 | ||
| Biomarkers of rheumatoid arthritis-associated interstitial lung disease | Q36218552 | ||
| Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis. | Q36949126 | ||
| Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis. | Q37277707 | ||
| MMP-7 and fcDNA serum levels in early NSCLC and idiopathic interstitial pneumonia: preliminary study | Q37420943 | ||
| Matrix metalloproteinase proteomics: substrates, targets, and therapy. | Q37555440 | ||
| Personalized medicine in idiopathic pulmonary fibrosis: facts and promises | Q38541522 | ||
| Biomarkers in the Evaluation and Management of Idiopathic Pulmonary Fibrosis | Q38595482 | ||
| New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis | Q39567618 | ||
| Plasma Surfactant Protein-D, Matrix Metalloproteinase-7, and Osteopontin Index Distinguishes Idiopathic Pulmonary Fibrosis from Other Idiopathic Interstitial Pneumonias. | Q39791661 | ||
| Matrix metalloproteinase-7 as a marker of metastasis and predictor of poor survival in bladder cancer. | Q39897988 | ||
| Serum metalloproteinases 1 and 7 in the diagnosis of idiopathic pulmonary fibrosis and other interstitial pneumonias | Q41587330 | ||
| Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosis | Q41830012 | ||
| Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis | Q43527848 | ||
| A multidimensional index and staging system for idiopathic pulmonary fibrosis | Q44564068 | ||
| Blood biomarkers MMP-7 and SP-A: predictors of outcome in idiopathic pulmonary fibrosis. | Q50954787 | ||
| An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline. | Q51612566 | ||
| Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. | Q52019566 | ||
| Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis. | Q53546521 | ||
| Impact of Blood Sampling on the Circulating Matrix Metalloproteinases 1, 2, 3, 7, 8, and 9 | Q62632426 | ||
| Concentrations of circulating gelatinases (matrix metalloproteinase-2 and -9) are dependent on the conditions of blood collection | Q81185787 | ||
| Production and activation of matrix metalloproteinase 7 (matrilysin 1) in the lungs of patients with idiopathic pulmonary fibrosis | Q84615570 | ||
| P433 | issue | 3 | |
| P921 | main subject | pulmonary fibrosis | Q32446 |
| P304 | page(s) | 486-493 | |
| P577 | publication date | 2016-10-19 | |
| P1433 | published in | Respirology | Q15753093 |
| P1476 | title | Validation of the prognostic value of MMP-7 in idiopathic pulmonary fibrosis | |
| P478 | volume | 22 |
| Q38669356 | An Ounce of Prevention… Will This Be the Future for IPF? |
| Q47213836 | An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study. |
| Q92763536 | Can monocytes predict prognosis of idiopathic pulmonary fibrosis? |
| Q90324721 | Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort |
| Q42101627 | Diagnosis of Idiopathic Pulmonary Fibrosis "Pragmatic Challenges in Clinical Practice" |
| Q90719647 | Gazing into the crystal ball: can treatment response be predicted in IPF? |
| Q97643286 | Identification of a unique temporal signature in blood and BAL associated with IPF progression |
| Q57170607 | Idiopathic Pulmonary Fibrosis (IPF): An Overview |
| Q52578942 | Impact of Transcriptomics on Our Understanding of Pulmonary Fibrosis. |
| Q92290037 | Matrisome-Associated Gene Expression Patterns Correlating with TIMP2 in Cancer |
| Q89696675 | Matrix Metalloproteinases Retain Soluble FasL-mediated Resistance to Cell Death in Fibrotic-Lung Myofibroblasts |
| Q33818813 | Microbial Antigens Stimulate Metalloprotease-7 Secretion in Human B-Lymphocytes Using mTOR-Dependent and Independent Pathways |
| Q38751135 | Serum Matrix Metalloproteinase-7, Respiratory Symptoms, and Mortality in Community-dwelling Adults: The Multi-Ethnic Study of Atherosclerosis |
| Q38673045 | Targets of Neutrophil Influx and Weaponry: Therapeutic Opportunities for Chronic Obstructive Airway Disease. |
| Q47262049 | Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study. |
| Q92422653 | WNT Signaling in Disease |
Search more.